|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||-60.87|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo FinanceGet free summary analysis Dyadic International, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Dyadic International, Inc. – E. I. du Pont de Nemours and Company, Codexis, Inc., Thermo Fisher Scientific Inc., Bioanalytical Systems, Inc., PerkinElmer, Inc., Senomyx, Inc. and Sevion Therapeutics, ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Dyadic International, Inc. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 0.49 million, Net Earnings of USD -2.06 million. Change in operating cash flow of 44.81% compared to same period last year is about the same as change in earnings, likely no significant ... Read more (Read more...)
This week marked the end of a longstanding legal battle between Jupiter biotechnology company Dyadic International and a group of prominent law firms that dates back to a 2007 dispute. “This settlement is the fourth and final in a series with various service providers and ends long-standing litigation. The agreement is the latest, and final, development in a lawsuit filed by Dyadic in 2009 against law firms, Greenberg Traurig, Jenkens & Gilchrist, Bilzin Sumberg Baena Price & Axelrod, and Moscowitz & Moscowitz.